An oversubscribed offering of about 55.5 million Chess Depositary Interests pulled in approximately $17.3 million for Osprey Medical. The company, which is seeking to obtain $8.2 million in an additional entitlement offer, intends to use the proceeds for US sales force expansion, post-approval market trials, a pilot sales program in Germany and continued research and development.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.